An Exploratory Study of Ganglioside GM1 in Acute Ischemic Stroke

NCT04952064 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Stroke, Ischemic

Interventions

DRUG: Monosialoganglioside GM1

Sponsor

General Hospital of Shenyang Military Region

Collaborators

[object Object]